rs754978707
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP2PP3
The NM_152384.3(BBS5):c.203A>G(p.Asn68Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000218 in 1,607,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152384.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BBS5 | NM_152384.3 | c.203A>G | p.Asn68Ser | missense_variant | Exon 3 of 12 | ENST00000295240.8 | NP_689597.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BBS5 | ENST00000295240.8 | c.203A>G | p.Asn68Ser | missense_variant | Exon 3 of 12 | 1 | NM_152384.3 | ENSP00000295240.3 | ||
| ENSG00000251569 | ENST00000513963.1 | c.203A>G | p.Asn68Ser | missense_variant | Exon 3 of 16 | 2 | ENSP00000424363.1 | |||
| BBS5 | ENST00000392663.6 | c.203A>G | p.Asn68Ser | missense_variant | Exon 3 of 11 | 1 | ENSP00000376431.2 | |||
| BBS5 | ENST00000443151.1 | n.143-858A>G | intron_variant | Intron 2 of 5 | 5 | ENSP00000406182.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 251070 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000234 AC: 34AN: 1455016Hom.: 0 Cov.: 29 AF XY: 0.0000179 AC XY: 13AN XY: 724302 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74312 show subpopulations
ClinVar
Submissions by phenotype
BBS5-related disorder Uncertain:1
The BBS5 c.203A>G variant is predicted to result in the amino acid substitution p.Asn68Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.023% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Bardet-Biedl syndrome Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 68 of the BBS5 protein (p.Asn68Ser). This variant is present in population databases (rs754978707, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with BBS5-related conditions. ClinVar contains an entry for this variant (Variation ID: 412294). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Bardet-Biedl syndrome 5 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at